Benzimidazole-2-Phenyl-Carboxamides as Dual-Target Inhibitors of BVDV Entry and Replication

Viruses. 2022 Jun 14;14(6):1300. doi: 10.3390/v14061300.

Abstract

Bovine viral diarrhea virus (BVDV), also known as Pestivirus A, causes severe infection mostly in cattle, but also in pigs, sheep and goats, causing huge economical losses on agricultural farms every year. The infections are actually controlled by isolation of persistently infected animals and vaccination, but no antivirals are currently available to control the spread of BVDV on farms. BVDV binds the host cell using envelope protein E2, which has only recently been targeted in the research of a potent and efficient antiviral. In contrast, RdRp has been successfully inhibited by several classes of compounds in the last few decades. As a part of an enduring antiviral research agenda, we designed a new series of derivatives that emerged from an isosteric substitution of the main scaffold in previously reported anti-BVDV compounds. Here, the new compounds were characterized and tested, where several turned out to be potent and selectively active against BVDV. The mechanism of action was thoroughly studied using a time-of-drug-addition assay and the results were validated using docking simulations.

Keywords: BVDV; antivirals; benzimidazole-2-phenyl-carboxamides; dual target; entry inhibition; replication inhibition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Benzimidazoles / pharmacology
  • Cattle
  • Diarrhea Viruses, Bovine Viral*
  • Pestivirus*
  • Sheep
  • Swine

Substances

  • Antiviral Agents
  • Benzimidazoles

Grants and funding

This research was funded by Fondazione di Sardegna through the grant “Bando Fondazione di Sardegna 2022 e 2023”.